scholarly journals Associations between the 2007 Medicare reimbursement reduction for bone mineral density testing and osteoporosis drug therapy patterns of female Medicare beneficiaries

2014 ◽  
pp. 909
Author(s):  
Ji Yoo ◽  
Sun Kim ◽  
Joo Lee ◽  
Sulgi Kim ◽  
Shunichi Nakagawa ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Drug Therapy ◽  
Bone Mineral ◽  
Medicare Reimbursement ◽  
Medicare Beneficiaries ◽  
Mineral Density ◽  
Bone Mineral Density Testing ◽  
Osteoporosis Drug

scholarly journals Regional Variation in the Denial of Reimbursement for Bone Mineral Density Testing Among US Medicare Beneficiaries

2008 ◽  
Vol 11 (4) ◽  
pp. 568-574 ◽  
Author(s):  
Jeffrey R. Curtis ◽  
Andrew J. Laster ◽  
David J. Becker ◽  
Laura Carbone ◽  
Lisa C. Gary ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Bone Mineral ◽  
Regional Variation ◽  
Medicare Beneficiaries ◽  
Mineral Density ◽  
Bone Mineral Density Testing

scholarly journals Effect of Self-referral on Bone Mineral Density Testing and Osteoporosis Treatment

Medical Care ◽  
2014 ◽  
Vol 52 (8) ◽  
pp. 743-750 ◽  
Author(s):  
Amy H. Warriner ◽  
Ryan C. Outman ◽  
Adrianne C. Feldstein ◽  
Douglas W. Roblin ◽  
Jeroan J. Allison ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Bone Mineral ◽  
Osteoporosis Treatment ◽  
Mineral Density ◽  
Bone Mineral Density Testing

scholarly journals Bone mineral density in children with long-term antiepileptic therapy

2013 ◽  
Vol 141 (5-6) ◽  
pp. 329-332 ◽  
Author(s):  
Milena Dimic ◽  
Aleksandar Dimic ◽  
Zoran Milosevic ◽  
Jelena Vojinovic
Keyword(s):  
Bone Mineral Density ◽  
Vitamin D ◽  
Drug Therapy ◽  
Antiepileptic Drug ◽  
Bone Mineral ◽  
Control Group ◽  
Mineral Density ◽  
Antiepileptic Therapy ◽  
Epileptic Children ◽  
Antiepileptic Drug Therapy

Introduction. Vitamin D active metabolites deficit that is altered by negative calcium and phosphorus balance is a potential complication during long?term antiepileptic drug therapy. Objective. The aim of this study was to examine lumbar bone mineral density (BMD) in epileptic children receiving antiepileptic drug therapy longer than one year. methods. The examined sample consisted of 34 epileptic children, 18 male and 16 female, aged 6?12 (9.77?2.01) years, treated with carbamazepine, valproate, phenobarbital, lamotrigine or their combination without vitamin D supplementation. The lumbar spine BMD (L1?L4) was estimated by a Lunar densitometer and obtained results were compared with results of 35 matched population of healthy children from the control group. results. Lumbar BMD Z?score was significantly lower in female patients treated with antiepileptic therapy compared with those in the control group (?1.048?1.35 vs. ?0.399?0.518; p=0.03). Bone mineral density Z?score decrease of both gender groups receiving antiepileptic polytherapy was significantly lower compared to the control group (?1.153?0.938 vs. ?0.043?0.815; p=0.007). Therapy duration had no influence on the lumbar BMD level decrease either in boys (rxy=0.33; p=0.174) or in girls (rxy=0.02; p=0.935) treated with antiepileptic therapy. Conclusion. Our results have indicated that antiepileptic drug therapy usage longer than one year can have adverse affects on the lumbar spine BMD (L1?L4) in epileptic children, and that prophylactic vitamin D supplementation is also necessary in these patients.

Bone mineral density testing: Is a T score enough to determine the screening interval?

2013 ◽  
Vol 80 (4) ◽  
pp. 234-239 ◽  
Author(s):  
Krupa B. Doshi ◽  
Leila Z. Khan ◽  
Susan E. Williams ◽  
Angelo A. Licata
Keyword(s):  
Bone Mineral Density ◽  
Bone Mineral ◽  
Mineral Density ◽  
Screening Interval ◽  
T Score ◽  
Bone Mineral Density Testing
Sign in / Sign up

Export Citation Format

Share Document